Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity
Daniel B. Maselli, Michael Camilleri
Advances in experimental medicine and biology (2020), pp. 171-192
Closed Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity
Martin Friedrichsen, Astrid Breitschaft, Sayeh Tadayon, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 3, pp. 754-762
Open Access | Times Cited: 247
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
Haiqiang Yao, Anqi Zhang, Delong Li, et al.
BMJ (2024), pp. e076410-e076410
Open Access | Times Cited: 156
Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy
Saullo Queiroz Silveira, Leopoldo Muniz da Silva, Arthur de Campos Vieira Abib, et al.
Journal of Clinical Anesthesia (2023) Vol. 87, pp. 111091-111091
Closed Access | Times Cited: 148
Gastrointestinal motility disorders in neurologic disease
Michael Camilleri
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 124
Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
Martin Bossart, Michael Wagner, Ralf Elvert, et al.
Cell Metabolism (2021) Vol. 34, Iss. 1, pp. 59-74.e10
Open Access | Times Cited: 124
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Juan José Gorgojo Martínez, Pedro Mezquita‐Raya, Juana Carretero Gómez, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 145-145
Open Access | Times Cited: 101
Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial
Daniel B. Maselli, Jessica Atieh, Matthew M. Clark, et al.
Obesity (2022) Vol. 30, Iss. 8, pp. 1608-1620
Open Access | Times Cited: 75
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
Zhaojun Wang, Xinru Li, Shi-Fan Chai, et al.
Neuropharmacology (2023) Vol. 240, pp. 109716-109716
Closed Access | Times Cited: 46
Fermented foods: Harnessing their potential to modulate the microbiota-gut-brain axis for mental health
Ramya Balasubramanian, Elizabeth Schneider, Eoin Gunnigle, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105562-105562
Open Access | Times Cited: 27
Glucagon-Like Peptide-1 Receptor Agonists Increase Solid Gastric Residue Rates on Upper Endoscopy Especially in Patients With Complicated Diabetes: A Case-Control Study
Kevin Garza, Eli Aminpour, Janaki Shah, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 6, pp. 1081-1088
Closed Access | Times Cited: 18
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Wajd Alkabbani, Karine Suissa, KRISTINE D. GU, et al.
BMJ (2024), pp. e080340-e080340
Closed Access | Times Cited: 17
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 6
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
Hon Jen Wong, Bee C. Sim, Yao Hao Teo, et al.
Diabetes Care (2025) Vol. 48, Iss. 2, pp. 292-300
Closed Access | Times Cited: 3
How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology (2025)
Open Access | Times Cited: 3
Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis
Kia Vosoughi, Jessica Atieh, Lehar Khanna, et al.
EClinicalMedicine (2021) Vol. 42, pp. 101213-101213
Open Access | Times Cited: 76
Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity
Mojca Jensterle, Simona Ferjan, Luka Ležaič, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 4, pp. 975-984
Open Access | Times Cited: 55
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist
Diego Añazco, Sima Fansa, Maria D. Hurtado, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 6, pp. 1333-1335.e2
Closed Access | Times Cited: 29
Anesthetic Considerations in Adult Patients on Glucagon-Like Peptide-1 Receptor Agonists: Gastrointestinal Focus
Girish P. Joshi
Anesthesia & Analgesia (2023)
Open Access | Times Cited: 26
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 23
The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
Azin Vakilpour, Ehsan Amini‐Salehi, Arman Soltani Moghadam, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: A retrospective single center observational study
Leonardo Barbosa Santos, Glenio B. Mizubuti, Leopoldo Muniz da Silva, et al.
Journal of Clinical Anesthesia (2024) Vol. 99, pp. 111668-111668
Open Access | Times Cited: 12
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials
Gustavo de Oliveira Almeida, Thiago Nienkötter, Caroline Cristine Almeida Balieiro, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 4, pp. 509-521
Closed Access | Times Cited: 11
POTENTIAL ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN SUBSTANCE USE DISORDER: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Silvia Martinelli, Alessandro Mazzotta, Mattia Longaroni, et al.
Drug and Alcohol Dependence (2024) Vol. 264, pp. 112424-112424
Open Access | Times Cited: 11
Perioperative management of patients on glucagon-like peptide-1 receptor agonists
Glenio B. Mizubuti, Anthony M.‐H. Ho, Leopoldo Muniz da Silva, et al.
Current Opinion in Anaesthesiology (2024) Vol. 37, Iss. 3, pp. 323-333
Closed Access | Times Cited: 9
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top